The role of integrative signaling between GPCR- and non-GPCR-mediated pathways is beginning to be realized in cancer [124,141] and such complex signaling mechanisms must also be elucidated for the highly tumorigenic CSC population. The gene discussed is LGR6; the disease is cancer.